Gillooly, K. M., Pulicicchio, C., Pattoli, M. A., Cheng, L., Skala, S., Heimrich, E. M., . . . Burke, J. R. (2017). Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care. PLoS One.
Citação norma ChicagoGillooly, Kathleen M., et al. "Bruton's Tyrosine Kinase Inhibitor BMS-986142 in Experimental Models of Rheumatoid Arthritis Enhances Efficacy of Agents Representing Clinical Standard-of-care." PLoS One 2017.
Citação norma MLAGillooly, Kathleen M., et al. "Bruton's Tyrosine Kinase Inhibitor BMS-986142 in Experimental Models of Rheumatoid Arthritis Enhances Efficacy of Agents Representing Clinical Standard-of-care." PLoS One 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.